|Number of samples:||4|
|Release date:||Sep 25 2018|
|Last update date:||Oct 2 2018|
|Diseases:||Fatty Liver, Liver Diseases|
|Dataset link||Targeting a phospho-STAT3-miRNAs pathway improves vesicular hepatic steatosis in an in vitro model|
ChIP-Seq for phospho-STAT3 with differentiated HepaRG cells treated for 4 days with 250 µM of sodium oleate or vehicle as control.